Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players√Ę‚ā¨‚ĄĘ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst

Asia Pacific Blood Glucose Test Strip Market Research Report Information: By Types (Glucose Oxidase, Glucose Dehydrogenase, other), Technology (Wicking Technology and Channel Technology), and End User (Hospital, Clinic, Household) -Forecast till 2030


ID: MRFR/MED/0182-HCR | 85 Pages | Author: Kinjoll Dey| April 2024

Asia Pacific Blood Glucose Test Strip Market Scenario


The Asia Pacific Blood Glucose Test Strip Market is expected to reach USD 3415.49 Million by 2030 at 5.80% CAGR during the forecast period 2022-2030.Diabetes a metabolic condition that occurs due to insufficient production of insulin. Blood glucose monitoring is a routine procedure for monitoring the glucose level. Blood glucose strip market is continuously growing in the Asia pacific region. These devices monitor the glucose level in the blood. Different types of strips are available in the market having impregnate of glucose oxidase, glucose dehydrogenase and other type of enzymes. When blood comes in the contact with this enzymes, they react with the glucose in the blood and indicates the blood glucose level. Advances and development in the technology has introduced the number of different devices in the market. The major driving factor for the Asia Pacific blood glucose test strip market is continuously increasing diabetes population. Diabetic population is constantly increasing and glucose level monitoring is an important part of diagnosis and treatment of diabetes. Patient with diseases, for instance, diabetes can now live longer and healthier life due to continuously monitoring of disease. Additionally, increasing awareness about preventive care of various diseases, rising obese population, and changing lifestyle boosting the growth of the Asia Pacific blood glucose test strip market. However, lack of accuracy and relatively high chances of false positive results may slow the growth of the Asia Pacific blood glucose test strip market.Figure- Asia Pacific blood glucose test strip market, by types Asia <a href='https://www.marketresearchfuture.com/reports/asia-pacific-blood-glucose-test-strip-packaging-market-626'>Pacific Blood</a> Glucose Test Strip Market


Source- World Health Organization (WHO, white paper, company presentation, annual report


Key Players Some of the major key players in the Asia Pacific blood glucose test strip market are F. Hoffmann-La Roche Ltd (Switzerland), Abbott (US), LifeScan, Inc. (US), i-SENS. Inc. (South Korea), AgaMatrix (US), TaiDoc Technology Corporation (Taiwan), BioSensors, Inc. (US), Universal Biosensors (Australia), Beijing Yicheng Electronic Co., Ltd (China), Hmd Biomedical (Taiwan), and B. Braun Melsungen Ag (Germany). Segmentation


Asia Pacific blood glucose test strip market is segmented on basis of types, technology and end users.

On the basis of types, the Asia Pacific blood glucose test strip market is segmented into glucose oxidase, glucose dehydrogenase, and other.


On the basis of technology, the Asia Pacific blood glucose test strip market is segmented into wicking technology and channel technology.


On the basis of end user, the Asia Pacific blood glucose test strip market is categorised in hospital, clinic, homecare and others


Regional Analysis Asia Pacific blood glucose test strip market is segmented into Japan, China, India, Australia, Republic of Korea and Rest of Asia Pacific. It is the fastest growing region in the global blood glucose strip market. The diabetic population in Asia Pacific is increasing continuously, which is the major driver the market. According to the World Health Organization (WHO), total diabetic population of India and China in 2012 was 61 million and 90 million respectively. Moreover, increasing awareness among the people, increasing healthcare expenditure and rising obese population have fuelled the growth of the market. China and India are the two major contributor to the Asia Pacific glucose test strip market owing to the presence of huge diabetic population.


Market Assessment Asia <a href='https://www.marketresearchfuture.com/reports/asia-pacific-blood-glucose-test-strip-packaging-market-626'>Pacific Blood</a> Glucose Test Strip Market-


Source: World Health Organization (WHO, white paper, company presentation, annual report


Intended Audience



  • Medical Devices manufacturers

  • Government and private research companies

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities

Report Attribute/Metric Details
  Market Size   USD 3415.49 Million
  CAGR   5.80% (2022-2030)
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Types, Technology & End User
  Geographies Covered   Asia Pacific
  Key Vendors F. Hoffmann-La Roche Ltd (Switzerland), Abbott (US), LifeScan, Inc. (US), i-SENS. Inc. (South Korea), AgaMatrix (US), TaiDoc Technology Corporation (Taiwan), BioSensors, Inc. (US), Universal Biosensors (Australia), Beijing Yicheng Electronic Co., Ltd (China), Hmd Biomedical (Taiwan), and B. Braun Melsungen Ag (Germany).
  Key Market Opportunities Increasing and glucose level monitoring is an important part of diagnosis and treatment of diabetes
  Key Market Drivers  Increasing healthcare expenditure and rising obese population have fuelled the growth of the market


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Request Free Sample
Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Ask for Customization